CliffBio
small molecule

ESTRADIOL

ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameESTRADIOL
Active ingredientESTRADIOL
Strength0.1% (1.25GM/PACKET)
Dosage formGEL
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalAugust 2023
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.